Whole Genome Amplification Market Size, Share, Trends, Growth and Forecast 2032

Whole Genome Amplification Market Insights

According to Zion Market Research, the global Whole Genome Amplification Market was worth USD 2.87 Billion in 2023. The market is forecast to reach USD 6.25 Billion by 2032, growing at a compound annual growth rate (CAGR) of 8.1% during the forecast period 2024-2032. The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Whole Genome Amplification Market industry over the next decade.

Request Free Sample

Whole Genome Amplification Market: Outlook

Whole genome amplification is a methodology for amplifying the complete genome commencing with nanogram DNA quantities and outputting microgram quantities of amplified products.  It is a major tool for the preservation of limited samples of DNA products and has been utilized for amplifying material from a single DNA cell. Many methods have been developed for whole genome amplification and this comprises degenerate oligonucleotide PCR, primer extension preamplification, and multiple displacement amplification.

Whole Genome Amplification Market: Growth Drivers

The surge in the aging population along with an increase in the cases of chronic diseases such as arthritis, heart disorders, and cancer will result in humungous growth of the whole genome amplification industry over the forecast timeline. A massive rise in the allocation of funds for carrying out clinical trials is expected to offer new opportunities for growth for the whole genome amplification industry over the assessment timeline.

According to one such study carried out by NIH researchers w.r.t whole genome amplification made from a single cell and from the findings of the study, it has been concluded that whole genome amplification is useful for diagnosis of genetic disease & forensics as well as accurately analyzing old samples of DNA. This will help in increasing the significance of whole genome amplification and will result in manifold growth of the market in the coming decade.

Request Free Sample

Furthermore, NCBI has stated that the use of whole genome amplification has gained momentum in the last few years and a polymerase chain reaction is used for replicating genomes of biological interest. Moreover, whole genome amplification finds a slew of applications including determining embryonic disorders, bioterrorism through genome detection, microbe diversity, genotyping, and clinical sample immortalization. Moreover, whole genome amplification has opened new vistas of growth for the molecular biology domain. All these aforementioned factors are anticipated to help the whole genome amplification industry mark a remarkable surge over the forecast timeframe.

Whole Genome Amplification Market: Report Scope

North American Market To Witness Acceleration In Growth By 2032

The expansion of the whole genome amplification industry in North America over the forecast timespan is owing to the massive allocation of funds by the U.S. government for carrying out research pertaining to genetic disorders as well as forensic science. Apart from this, a rise in the number of pharma firms in the countries such as Canada and the U.S. focusing on whole genome amplification activities will further proliferate the expansion of the whole genome amplification market in the sub-continent over the assessment period. In addition to this, the thriving genetic engineering domain in the sub-continent will make remarkable contributions toward the whole genome amplification market size in the years ahead.

Key participants profiled in the study include:

• Qiagen NV
• LGC Group
• Sigma-Aldrich
• GE Healthcare.

The global whole genome amplification market is segmented as follows:

By type:

• Single Cell WGA Kit
• Complete WGA Kit
• WGA Reamplification Kit
• WGA & Chip DNA Kit
• Others

By application:

• Drug Discovery & Development
• Disease Diagnosis
• Agriculture & Veterinary
• Research
• Forensics
• Others

By end-user:

• Pharmaceutical & Biotech Companies
• Contract Research
• Hospitals & Clinics
• Research & Academic Institutes
• Organizations
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of The Middle East & Africa